We then analyzed the relationships between PSMB8- versus PSMB9-expressing tumor cells (CK8-18+, CD45-), stromal cells (CK8-18-, CD45-) and immune cells (CK8-18-, CD45+). Here, PTPRC is linked to neoplasm.